Form 4 for ORKA Oruka Therapeutics, Inc.
Accepted 2026-09-21 17:38:50 ET · period of report 2026-09-21 · accession 0000907654-26-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-21 17:38 | 2026-09-21 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale | $95.75 | -533 | 14.2K | -4% | -$51.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-21 | S | D | 533 | $95.75 | 14,219 | D | — | — | (F1) These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026. |